Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
RECRUITINGPhase 3NCT06829784
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
This study is a multicenter, randomized, double-blind, parallel-group, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of TQC2731...
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Enrolling: 66020 locations
Asthma
RECRUITINGPhase 1 / Phase 2NCT07266116
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain...
This study is a clinical trial aimed at the marketing of TQB2934 for injection. The project plans to enroll 70 subjects, including 13-21 subjects in Phase Ib, to evaluate the...
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Enrolling: 7020 locations
Systemic Light Chain Amyloidosis